Structural insights into differences in G protein activation by family A and family B GPCRs
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Revealing family differences: In response to low blood glucose concentrations, both the glucagon receptor (GCGR)—a family B G protein–coupled receptor (GPCR)—and the β 2 adrenergic receptor (β 2 AR)—a family A GPCR—are activated and act through the cyclic adenosine monophosphate signaling pathway to increase glucose production. The kinetics of the response is different for the two receptors. Based on structural and spectroscopic data, Hilger et al. show that the conformation of transmembrane helix 6 in the activated state is a key differentiator (see the Perspective by Lebon). In β 2 AR, the helix moves toward its active conformation when an agonist binds, but in GCGR, both agonist and G protein binding are required. This likely explains why activation of its partner G protein is slower for GCGR than for β 2 AR. Science , this issue p. eaba3373 ; see also p. 507
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scalable molecular dynamics with NAMD
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20289 · Cited by 16,914
UCSF ChimeraX: Meeting modern challenges in visualization and analysis
Goddard, T. D., Huang, C. C., Meng, E. C., Pettersen, E. F., Couch, G. S., Morris, J. H., & Ferrin, T. E. (2018) · Protein Science · doi:10.1002/pro.3235 · Cited by 5,267
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Self-citationCryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160 · cited 5×
“Because of its fundamental role in glucose homeostasis, GCGR represents an important therapeutic target for the treatment of severe hypoglycemia in diabetic patients (11).”
BackgroundMethodInfluentialGlucagon and regulation of glucose metabolism
Jiang, G., & Zhang, B. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2002 · Cited by 905 · cited 5×
“Ligands and their sources were as follows: (-)-isoproterenol hydrochloride (Sigma-Aldrich) for b2AR; serotonin (5-hydroxytryptamine hydrochloride; FUJIFILMWakoPureChemical) for 5-HT4; prostaglandin D2 (Cayman Chemical) for DP; histamine dihydrochloride (FUJIFILM Wako Pure Chemical) for H2R; arginine vasopressin (Pepti…”
BackgroundMethodInfluentialThe New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
Structure and dynamics of the active human parathyroid hormone receptor-1
Zhao, L.-H., Ma, S., Sutkeviciute, I., Shen, D.-D., Zhou, X. E., de Waal, P. W., Li, C.-Y., Kang, Y., Clark, L. J., Jean-Alphonse, F. G., et al. (2019) · Science · doi:10.1126/science.aav7942 · Cited by 256
Hövelmann, U., Bysted, B. V., Mouritzen, U., Macchi, F., Lamers, D., Kronshage, B., Møller, D. V., & Heise, T. (2018) · Diabetes Care · doi:10.2337/dc17-1402 · Cited by 115 · cited 5×
“Ligands and their sources were as follows: (-)-isoproterenol hydrochloride (Sigma-Aldrich) for b2AR; serotonin (5-hydroxytryptamine hydrochloride; FUJIFILMWakoPureChemical) for 5-HT4; prostaglandin D2 (Cayman Chemical) for DP; histamine dihydrochloride (FUJIFILM Wako Pure Chemical) for H2R; arginine vasopressin (Pepti…”
MethodInfluential
Cited by
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
GPCR activation mechanisms across classes and macro/microscales
Hauser, A. S., Kooistra, A. J., Munk, C., Heydenreich, F. M., Veprintsev, D. B., Bouvier, M., Babu, M. M., & Gloriam, D. E. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00674-7 · Cited by 301
Multi‐state modeling of G‐protein coupled receptors at experimental accuracy
Heo, L., & Feig, M. (2022) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26382 · Cited by 215
“Moreover, in contrast to class A GPCRs, the activation of class B GPCRs involve significant structural changes such as a break of the TM6 helix with a high-energy barrier.(37) In the case of such complex pathways, it was difficult to capture intermediate states with our protocol (e.”
BackgroundZhao, F., Zhou, Q., Cong, Z., Hang, K., Zou, X., Zhang, C., Chen, Y., Dai, A., Liang, A., Ming, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28683-0 · Cited by 149
Mechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor
Batebi, H., Pérez-Hernández, G., Rahman, S. N., Lan, B., Kamprad, A., Shi, M., Speck, D., Tiemann, J. K. S., Guixà-González, R., Reinhardt, F., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01334-2 · Cited by 38
Self-citation
Metadata
- Authors
- Hilger, D., Kumar, K. K., Hu, H., Pedersen, M. F., O’Brien, E. S., Giehm, L., Jennings, C., Eskici, G., Inoue, A., Lerch, M., Mathiesen, J. M., Skiniotis, G., & Kobilka, B. K.
- Venue
- Science
- Published
- 2020-07-31
- Volume
- 369
- Issue
- 6503
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3046840768
- Cited by
- 152
- References
- 8
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.